MTRNR2L11: A Drug Target / Disease Biomarker (G100463489)

Target Name: MTRNR2L11

NCBI ID: G100463489

MTRNR2L11

Other Name(s): MT-RNR2 like 11 | HN11 | MT-RNR2 like 11 (pseudogene)

MTRNR2L11: A Drug Target / Disease Biomarker

MTRNR2L11 is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. The MTRNR2L11 gene is located on chromosome 6p21 and encodes for a non-coding RNA molecule that has been shown to play a role in regulating gene expression and has been associated with various diseases.

One of the unique features of MTRNR2L11 is its expression pattern. The molecule is typically expressed in the brain and has been found to be highly expressed in regions of the brain that are affected by neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. This suggests that MTRNR2L11 may be a useful biomarker for these conditions.

In addition to its expression pattern, MTRNR2L11 has also been shown to play a role in the regulation of gene expression. Studies have shown that the MTRNR2L11 RNA molecule can interact with certain genes and regulate their expression. This suggests that MTRNR2L11 may be a useful drug target for diseases that are caused by the over-expression or deregulation of specific genes.

Another potential application of MTRNR2L11 as a drug target is its role in the regulation of cellular processes that are important for brain function. Studies have shown that MTRNR2L11 is involved in the regulation of microRNA (miRNA) levels, which are small non-coding RNAs that play a critical role in regulating gene expression in the brain. The regulation of miRNA levels is important for the normal functioning of the brain and may be implicated in the development and progression of various psychiatric and neurological disorders. Therefore, MTRNR2L11 may be a useful target for drugs that are designed to modulate miRNA levels in the brain.

In conclusion, MTRNR2L11 is a gene that has been identified as a potential drug target or biomarker for various diseases. Its expression pattern and role in regulating gene expression make it an attractive target for small molecule inhibitors or RNA-based therapeutics. Further research is needed to determine the exact mechanisms by which MTRNR2L11 contributes to the development and progression of various diseases, as well as to identify small molecule inhibitors or RNA-based therapeutics that can modulate its activity.

Protein Name: MT-RNR2 Like 11 (pseudogene)

Functions: Plays a role as a neuroprotective and antiapoptotic factor

The "MTRNR2L11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MTRNR2L11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets